
Sign up to save your podcasts
Or
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering listeners a deep understanding of the effectiveness and timeline of Anifrolumab treatment.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000761
3.9
1414 ratings
Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discusses the time to onset of clinical response to Anifrolumab in patients with Systemic Lupus Erythematosus. The episode delves into pooled data from two significant Phase III trials, TULIP-1 and TULIP-2, offering listeners a deep understanding of the effectiveness and timeline of Anifrolumab treatment.
Read the article: http://dx.doi.org/10.1136/lupus-2022-000761
11,115 Listeners
39 Listeners
4 Listeners
55 Listeners
7 Listeners
4 Listeners
3 Listeners
1 Listeners
4 Listeners
9 Listeners
41 Listeners
14 Listeners
1 Listeners
46 Listeners
0 Listeners
6 Listeners
493 Listeners
277 Listeners
3,323 Listeners
3 Listeners
87 Listeners
27 Listeners
1,084 Listeners
1,674 Listeners
23 Listeners
350 Listeners
23 Listeners
30 Listeners
364 Listeners
42 Listeners
2 Listeners
0 Listeners
0 Listeners
0 Listeners